Who owns BioMarin Pharmaceutical (BMRN)? Superinvestor holders

3 superinvestors of the 157 tracked here hold BioMarin Pharmaceutical (BMRN) in their latest 13F filing, with $2.2B between them. Andreas Halvorsen gives it the most weight: 1.24% of the reported portfolio. In their latest reported quarter, Andreas Halvorsen and Primecap team added; Dodge & Cox team reduced.

Steve Cohen and Ken Fisher sold out of it in their latest quarter.

Hold it now
3
of 157 tracked
Combined value
$2.2B
Bought / sold
2 / 3
last quarter

Key facts

Superinvestors holding it
3 of 157
Biggest holder
Primecap team, $899.3M
Largest weight
Andreas Halvorsen, 1.24%of their portfolio
Combined value
$2.2B
Bought last quarter
2
Sold last quarter
3

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding BMRN, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Andreas HalvorsenViking Global Investors1.24%$435.8M7.62M▲ Added 7.9%+554.38KQ2 2026
2Primecap teamPrimecap Management0.56%$899.3M14.99M▲ Added 5.6%+798.9KQ3 2026
3Dodge & Cox teamDodge & Cox0.47%$877.5M14.63M▼ Reduced 1.5%−219.71KQ3 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of BMRN by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 202692229.61M$1.8B12
Q2 2026157336.65M$2.1B22
Q1 2026157548.01M$2.7B34
Q4 2025157745.38M$2.7B43
Q3 2025157444.17M$2.4B13
Q2 2025157551.58M$2.8B42
Q1 2025156549.95M$3.5B31
Q4 2024156446.95M$3.1B22

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of BMRN held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Primecap team14.99M14.19M14.19M14.55M15.23M15.77M17.77M18.19M
Dodge & Cox team14.63M14.84M14.56M14.57M14.69M15.11M14.96M14.75M
Andreas Halvorsen·7.62M7.06M6.04M8.32M12.29M10.8M10.51M
Cliff Asness·—7.68M6.69M5.93M5.58M2.93M—
Ken Griffin·—4.51M—————
Israel Englander·——3.04M—2.83M——
Louis Bacon———325K————
Robert Pitts·——168K————
Paul Singer·—————3.5M3.5M

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own BMRN?

In their latest 13F filings: Andreas Halvorsen (1.24% of the portfolio, $435.8M), Primecap team (0.56% of the portfolio, $899.3M), Dodge & Cox team (0.47% of the portfolio, $877.5M).

Who bought BMRN last quarter?

Andreas Halvorsen (added 7.9%), Primecap team (added 5.6%). “Last quarter” is each investor's latest reported quarter.

Who sold BMRN last quarter?

Reduced: Dodge & Cox team (1.5% fewer shares). Sold out entirely: Steve Cohen (was $67.7M), Ken Fisher (was $2M).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns BioMarin Pharmaceutical (BMRN)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/BMRN/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to BMRN by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.